Federal
Register Notices > Importers
>
American Custom Chemicals Corporation
FR Doc E7-23187 [Federal Register: November 30, 2007 (Volume 72, Number
230)] [Notices] [Page 67758] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr30no07-83]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21
U.S.C. 958(i), the Attorney General shall, prior to issuing a registration
under this section to a bulk manufacturer of a controlled substance in
schedule I or II and prior to issuing a registration under 21
U.S.C. 952(a)(2) authorizing the importation of such a substance, provide
manufacturers holding registrations for the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with title 21 Code of Federal Regulations (CFR), 1301.34(a),
this is notice that on May 8, 2007, American Custom Chemicals Corporation,
6650 Lusk Boulevard, Suite B102, San Diego, California 92121, made application
to the Drug Enforcement Administration (DEA) to be registered as an importer
of Sufentanil (9740), a basic class of controlled substance listed in schedule
II.
The company plans to import the listed controlled substance for research
purposes only.
Any bulk manufacturer who is presently, or is applying to be, registered
with DEA to manufacture such basic class of controlled substance may file
comments or objections to the issuance of the proposed registration and may,
at the same time, file a written request for a hearing on such application
pursuant to 21
CFR 1301.43 and in such form as prescribed by 21
CFR 1316.47.
Any such comments or objections being sent via regular mail should be
addressed, in quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), Washington, DC
20537, or any being sent via express mail should be sent to Drug Enforcement
Administration, Office of Diversion Control, Federal Register Representative (ODL),
8701 Morrissette Drive, Springfield, VA 22152; and must be filed no later than
December 31, 2007.
This procedure is to be conducted simultaneously with, and independent of,
the procedures described in 21
CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice
published in the Federal Register on September 23, 1975, (40 FR 43745-43746),
all applicants for registration to import a basic class of any controlled
substances in schedule I or II are and will continue to be required to
demonstrate to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, that the requirements for such
registration pursuant to 21
U.S.C. 958(a); 21
U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: November 20, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-23187 Filed 11-29-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|